Breast cancer

Showing 9 of 0 results

• Flatiron Health Announces Upcoming Research Presentations at the San Antonio Breast Cancer Symposium 2024
  • Press releases
  • Breast cancer
• Real-world demographics, clinical characteristics, and treatment patterns among US patients with HER2-negative early breast cancer and germline BRCA mutations since 2021

  San Antonio Breast Cancer Symposium

  • Publication summary
  • Publications
  • Breast cancer
• Clinical characteristics and treatment persistence in US patients with HR+/HER2-, node positive early breast cancer treated with abemaciclib: Real-world study from first year after approval

  San Antonio Breast Cancer Symposium

  • Publication summary
  • Publications
  • Breast cancer
• Tolerability of first-line treatment with ribociclib for metastatic breast cancer using two large US data sources

  San Antonio Breast Cancer Symposium

  • Publication summary
  • Publications
  • Metastatic breast cancer
  • Breast cancer
• Comparative overall survival of CDK4/6is plus an aromatase inhibitor in HR+/HER2- metastatic breast cancer in the US real-world setting

  San Antonio Breast Cancer Symposium

  • Publication summary
  • Publications
  • Metastatic breast cancer
  • Breast cancer
• Real-World Evidence Bolsters Breast Cancer Research at Every Step of the Therapeutic Development Lifecycle
  • Real-world evidence
  • Case study
  • Article
  • Breast cancer
• What is currently top of mind for breast cancer industry experts?
  • Real-world evidence
  • Clinical research
  • Event recap
  • Metastatic breast cancer
  • Breast cancer
• Bridging Innovation and Practice: The Current and Future Landscape of Breast Cancer Care
  • Real-world evidence
  • Clinical research
  • Video
  • Breast cancer
• ASCO 2024 reflections and highlights
  • Real-world evidence
  • Clinical research
  • Event recap
  • Drug discovery
  • Prospective study
  • Breast cancer
  • Trial design
  • Artificial intelligence